Related references
Note: Only part of the references are listed.Acyclovir for Mechanically Ventilated Patients With Herpes Simplex Virus Oropharyngeal Reactivation A Randomized Clinical Trial
Charles-Edouard Luyt et al.
JAMA INTERNAL MEDICINE (2020)
Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)
Richard S. Hotchkiss et al.
CRITICAL CARE MEDICINE (2019)
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Per Ljungman et al.
LANCET INFECTIOUS DISEASES (2019)
Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO
Sami Hraiech et al.
ANNALS OF INTENSIVE CARE (2019)
Advances in the understanding and treatment of sepsis-induced immunosuppression
Fabienne Venet et al.
NATURE REVIEWS NEPHROLOGY (2018)
Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients
Dominika Deborska-Materkowska et al.
BMC INFECTIOUS DISEASES (2018)
Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis
Xi Li et al.
BMC INFECTIOUS DISEASES (2018)
Autopsy-detected diagnostic errors over time in the intensive care unit
Eva E. Tejerina et al.
HUMAN PATHOLOGY (2018)
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2018)
Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis
Emma M. Pinder et al.
THORAX (2018)
Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
Bruno Francois et al.
JCI INSIGHT (2018)
Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis
Yoichiro Natori et al.
CLINICAL INFECTIOUS DISEASES (2018)
Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study
Kirsten van de Groep et al.
CRITICAL CARE (2018)
Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness A Randomized Clinical Trial
Ajit P. Limaye et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients A Randomized Clinical Trial
Nicholas J. Cowley et al.
JAMA INTERNAL MEDICINE (2017)
Association Between Cytomegalovirus Reactivation and Clinical Outcomes in Immunocompetent Critically Ill Patients: A Systematic Review and Meta-Analysis
Philippe Lachance et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Epidemiology of Multiple Herpes Viremia in Previously Immunocompetent Patients With Septic Shock
David S. Y. Ong et al.
CLINICAL INFECTIOUS DISEASES (2017)
CRITICAL ILLNESS-INDUCED IMMUNE SUPPRESSION: CURRENT STATE OF THE SCIENCE
Kristin C. Greathouse et al.
AMERICAN JOURNAL OF CRITICAL CARE (2016)
Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome
David S. Y. Ong et al.
INTENSIVE CARE MEDICINE (2016)
Interferon-γ production by CMV-specific CD8+T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients
Juan Jose Caston et al.
INTENSIVE CARE MEDICINE (2016)
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cytomegalovirus infection in patients with sepsis due to bloodstream infections: lower risk and better outcomes in new versus already hospitalised intensive care unit admissions
R. Osawa et al.
ANAESTHESIA AND INTENSIVE CARE (2016)
Coreactivation of Human Herpesvirus 6 and Cytomegalovirus Is Associated With Worse Clinical Outcome in Critically III Adults
Paula Lopez Roa et al.
CRITICAL CARE MEDICINE (2015)
Cytomegalovirus Seroprevalence as a Risk Factor for Poor Outcome in Acute Respiratory Distress Syndrome
David S. Y. Ong et al.
CRITICAL CARE MEDICINE (2015)
Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: Incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers
Frantzeska G. Frantzeskaki et al.
JOURNAL OF CRITICAL CARE (2015)
The pathogenesis of human cytomegalovirus
Paul Griffiths et al.
JOURNAL OF PATHOLOGY (2015)
Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series
Corine E. Delsing et al.
BMC INFECTIOUS DISEASES (2014)
Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: pro
Jean-Marie Forel et al.
INTENSIVE CARE MEDICINE (2014)
Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: con
G. Chanques et al.
INTENSIVE CARE MEDICINE (2014)
Looking for biological factors to predict the risk of active cytomegalovirus infection in non-immunosuppressed critically ill patients
Dayana Bravo et al.
JOURNAL OF MEDICAL VIROLOGY (2014)
Reactivation of Multiple Viruses in Patients with Sepsis
Andrew H. Walton et al.
PLOS ONE (2014)
The impact of cytomegalovirus infection on mechanically ventilated patients in the respiratory and geriatric intensive care units
Nehad M. Osman et al.
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS (2014)
Pretransplant Interferon- Secretion by CMV-Specific CD8+T Cells Informs the Risk of CMV Replication After Transplantation
S. Cantisan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Evaluation of cytomegalovirus (CMV)-specific t-cell immunity for the assessment of the risk of active CMV infection in non-immunosuppressed surgical and trauma intensive care unit patients
Maria A. Clari et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
Cytomegalovirus serostatus and outcome in nonimmunocompromised critically ill patients
Greet De Vlieger et al.
CRITICAL CARE MEDICINE (2012)
Interferon-γ production by natural killer cells and cytomegalovirus in critically ill patients
Laurent Chiche et al.
CRITICAL CARE MEDICINE (2012)
A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury
Robert Paine et al.
CRITICAL CARE MEDICINE (2012)
Cytomegalovirus and Herpes Simplex Virus Effect on the Prognosis of Mechanically Ventilated Patients Suspected to Have Ventilator-Associated Pneumonia
Yannael Coisel et al.
PLOS ONE (2012)
Diagnostic errors in the intensive care unit: a systematic review of autopsy studies
Bradford Winters et al.
BMJ QUALITY & SAFETY (2012)
Cytomegalovirus infection in severe burn patients monitoring by real-time polymerase chain reaction: A prospective study
J. Bordes et al.
BURNS (2011)
Cytomegalovirus infection in non-immunosuppressed critically ill patients
Manisha Jain et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2011)
Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients
Caroline Guignant et al.
CRITICAL CARE (2011)
Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis
Alexandra Heininger et al.
CRITICAL CARE (2011)
Virological and Immunological Features of Active Cytomegalovirus Infection in Nonimmunosuppressed Patients in a Surgical and Trauma Intensive Care Unit
Marifina Chilet et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Immunotherapy for Sepsis - A New Approach against an Ancient Foe
Richard S. Hotchkiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
CMV in critically ill patients: pathogen or bystander?
Ajit P. Limaye et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection
Michael J. Cannon et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
Granulocyte-Macrophage Colony-stimulating Factor to Reverse Sepsis-associated Immunosuppression A Double-Blind, Randomized, Placebo-controlled Multicenter Trial
Christian Meisel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Cytomegalovirus reactivation and mortality during critical illness: A $64,000 question
Charles H. Cook
CRITICAL CARE MEDICINE (2009)
Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients
Laurent Chiche et al.
CRITICAL CARE MEDICINE (2009)
Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit
Andre C. Kalil et al.
CRITICAL CARE MEDICINE (2009)
Increased mortality in long-term intensive care patients with active cytomegalovirus infection
Malte Ziemann et al.
CRITICAL CARE MEDICINE (2008)
Reactivation of Cytomegalovirus Infection in Critically Ill Immunocompetent Patients Reply
Ajit P. Limaye et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Hydrocortisone therapy for patients with septic shock
Charles L. Sprung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Comparison of clinical and post-mortem findings in intensive care unit patients
Calliope Maris et al.
VIRCHOWS ARCHIV (2007)
A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients
Laurent Papazian et al.
CRITICAL CARE MEDICINE (2007)
Active cytomegalovirus infection in patients with septic shock
Lutz von Mueller et al.
EMERGING INFECTIOUS DISEASES (2006)
Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1β triggers reactivation of latent cytomegalovirus in immunocompetent mice
Charles H. Cook et al.
JOURNAL OF VIROLOGY (2006)
Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice
CH Cook et al.
CRITICAL CARE MEDICINE (2006)
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
AW Sylwester et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury
PE Parsons et al.
CRITICAL CARE MEDICINE (2005)
Cytomegalovirus infection in critically ill patients - Associated factors and consequences
S Jaber et al.
CHEST (2005)
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
MK Gandhi et al.
LANCET INFECTIOUS DISEASES (2004)
Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy
JR Deayton et al.
LANCET (2004)
Occult herpes family viral infections are endemic in critically ill surgical patients
CH Cook et al.
CRITICAL CARE MEDICINE (2003)
Intra-abdominal bacterial infection reactivates latent pulmonary cytomegalovirus in immunocompetent mice
CH Cook et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Human cytomegalovirus infections in nonimmunosuppressed critically ill patients
A Heininger et al.
CRITICAL CARE MEDICINE (2001)
A novel link between stress and human cytomegalovirus (HCMV) infection:: Sympathetic hyperactivity stimulates HCMV activation
S Prösch et al.
VIROLOGY (2000)
Share Paper
